Carbaglu is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases. The primary component is Carglumic Acid.
| Product ID | 52276-312_2214969d-cb0e-438d-b329-c78e72d0198b |
| NDC | 52276-312 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Carbaglu |
| Generic Name | Carglumic Acid |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-03-18 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022562 |
| Labeler Name | Recordati Rare Diseases |
| Substance Name | CARGLUMIC ACID |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2010-03-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022562 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-03-18 |
| Marketing Category | NDA |
| Application Number | NDA022562 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-03-18 |
| Ingredient | Strength |
|---|---|
| CARGLUMIC ACID | 200 mg/1 |
| SPL SET ID: | 10175e73-5172-4dde-a508-8a88b7afc0a1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52276-312 | Carbaglu | Carglumic Acid |
| 35573-459 | Carglumic acid | Carglumic acid |
| 68475-006 | Carglumic acid | Carglumic acid |
| 70954-120 | Carglumic Acid | Carglumic Acid |
| 71863-114 | Carglumic Acid | Carglumic Acid |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CARBAGLU 76500798 2876444 Live/Registered |
RECORDATI ORPHAN DRUGS 2003-03-26 |